ClinicalTrials.Veeva

Menu

Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer

T

tiejun Zhang

Status

Unknown

Conditions

Tongue Cancer

Treatments

Procedure: inhalational anesthesia
Procedure: combined intravenous-inhalational anesthesia
Procedure: intravenous anesthesia

Study type

Interventional

Funder types

Other

Identifiers

NCT01854021
wuhan university

Details and patient eligibility

About

Surgical excision is the mainstay of treatment for tongue cancer. However, surgery-induced immunosuppression has been implicated in the development of post-operative septic complications and neoplasm metastasis. General anesthesia is considered to not only suppress surgical stress, but also affect the immune function directly,such as altering the number and activity of immune cells. It is reported that some anesthetics increase susceptibility to tumor metastasis, apparently by suppressing natural killer cell activity. Different anesthetic techniques and anesthetics used in anesthesia have shown different effects on immunity. Many of the studies were animal trials or performed in vitro; in addition, most are focused on a single drug. To date, there is little published prospective clinical research designed specifically to investigate the effects of different general anesthetic technique on immune function in patients with oral malignant tumors. The aim of this study is going to characterize the immune response of patients undergoing surgery for tongue cancer under 3 types of general anesthesia.

Enrollment

60 estimated patients

Sex

All

Ages

50 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All the patients were scheduled for elective surgery for tongue cancer under general anesthesia. None of the patients had a history of endocrine, immune and circulatory system diseases;
  • Exclusion criteria were also contraindications for receiving chemotherapy

Exclusion criteria

  • contraindications for receiving chemotherapy,
  • receiving perioperative blood transfusion, or
  • preoperative and perioperative treatment with hormones and immunomodulatory agent.

Patients who suffered from any surgical complications such as infection were also excluded from our study.

Trial design

60 participants in 3 patient groups

inhalational anesthesia
Experimental group
Description:
inhalational anesthesia
Treatment:
Procedure: inhalational anesthesia
combined intravenous-inhalational anesthesia
Experimental group
Description:
combined intravenous-inhalational anesthesia
Treatment:
Procedure: combined intravenous-inhalational anesthesia
intravenous anesthesia
Experimental group
Description:
intravenous anesthesia
Treatment:
Procedure: intravenous anesthesia

Trial contacts and locations

1

Loading...

Central trial contact

tiejun zhang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems